US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 4.850
  • +0.220+4.75%
Close Feb 28 16:00 ET
  • 4.850
  • 0.0000.00%
Post 16:16 ET
269.72MMarket Cap-2.62P/E (TTM)

Foghorn Therapeutics Key Stats

Foghorn Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.360M--
--2024/Q4-- / 8.559M--
--2024/Q37.808M / 7.010M--
--2024/Q26.888M / 6.726M--
--2024/Q15.050M / 7.352M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.360M--
--2024/Q4-- / 8.559M--
--2024/Q37.808M / 7.010M--
--2024/Q26.888M / 6.726M--
--2024/Q15.050M / 7.352M--

Unlock Free Earnings Estimates

Foghorn Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Strong Buy

  • Buy

    83.33%
  • Hold

    16.67%
  • Sell

    0.00%

Price Target

No Data